Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverCVSI
HealthcareOQBUSD

CV Sciences, Inc.

$00123456789.00123456789001234567890.0%
52w low $0.01$0.10 52w high
Market data · last updated 1d ago
Market data
Market cap
$4.08M
52w range
$0.01 - $0.10
Beta
0.44
Sector
Healthcare
Data quality
83/100
Valuation
fair value estimate
$0.01
Margin of safety
0.0%
Quality & efficiency
Moat score
27/100
Return on equity
-88.0%
Profit margin
-11.2%
Debt / equity
0.99
Growth & analysts
Revenue growth
-11.4%
Run the 10-point checklist before you buy How these numbers are made

About CV Sciences, Inc.

CV Sciences, Inc. engages in the development, manufacture, marketing, and sale of herbal supplements, hemp-based cannabidiol (CBD), and plant-based food products in North America. It offers its products under the PlusCBD, PlusCBD Pet, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.

Valuation

ValueGrowthProfitHealthIncome26QUALITY
Overall Rating
20
Very low quality
Very low quality

Derived from filed metrics · High confidence (83% of the inputs available)

Moat Score27
Fair value estimate
$0.010.0% upside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$4.08M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
-11.4%
Profit Margin
-11.2%
ROE
-88.0%
Debt / Equity
0.99
Beta
0.44
Beaten Down

Statistics

Similar Stocks · Healthcare

Latest News · CVSI